The butantan institute and the brazilian anticovid vaccine

Abstract

The text explores the theme of Brazilian sufficiency in vaccines. It presents the ways prac-ticed in the two most important Brazilian institu-tions in the development and production of vaccines-the Butantan Institute and the Institute of Technology in Immunobiologicals (Bio-Mangui-nhos). These paths are the pure and simple pur-chase, the purchase of the product with technology transfer commitment, partnerships that include the fulfillment of phase 3 trials by the buyer, the new path announced by Instituto Butantan in which the partnership includes for the realization of trials in phases 1 and 2 and, finally, the inven-tion, development and local vaccine production. The latter is only mentioned as a possibility cur-rently not achieved. Finally, the text presents data on the chances of success in vaccine development.